Health care company PainChek (ASX:PCK) is set to raise about AU$5.1 million through a fully underwritten non-renounceable, pro-rata entitlement offer to shareholders on the basis of one new share for every eight shares held, priced at $0.025 apiece, according to a Monday filing with the Australian bourse.
The offer comes with one free attaching new option, with an exercise price of AU$0.05 and a 12-month expiry, for every new share issued, the filing said.
The proceeds will support the expansion of ANZ and UK Adult App sales in aged care and home care sectors, North American market entry post US Food and Drug Administration clearance, completion of Infant App commercial launch, and financing preparation, according to the filing.
PainChek shares rose nearly 4% in afternoon trade Monday.
Price (AUD): $0.03, Change: $+0.001, Percent Change: +3.57%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。